James P. Talbert
Associate
[javascript protected email address]
direct 614.229.3235
assistant 614.229.3361
Overview
James focuses his practice on directors and officers liability insurance, professional liability insurance, and coverage litigation. He serves as coverage and monitoring counsel for insurance companies that provide primary and excess coverage to a broad spectrum of policyholders, including public and private companies, investment funds, and municipalities. James is proactive and strategic in advancing his clients’ interests, and he enjoys positioning the carriers he represents to achieve the optimal outcome in any given scenario.
In addition to his coverage work, James assists insurance carriers with regulatory and corporate matters, including licensure issues, product regulation, and M&A deals. In all aspects of his practice, James is committed to providing his clients with the most effective counsel and representation for their legal needs.
Practice Areas
Credentials
Education
The Ohio State University Moritz College of Law (J.D., 2015) cum laude
The Ohio State University (B.A., 2010) cum laude
Bar Admissions
Ohio
Professional Highlights
Publications & Speaking Engagements
- 7th Circuit Joins Trend Of No CGL Coverage For Structural Flaws
- Guest Post: Litigation Risks and Insurance Issues for SPAC Sponsors, The D&O Diary (Feb. 15, 2022), available here
- Guest Post: The Year in Review: 2021 Key D&O Insurance Coverage Decisions, The D&O Diary (Jan. 25, 2022), available here
- Guest Post: Divergent Trends Regarding Application of the Insured vs. Insured Exclusion for Mixed Actions, Guest Post, The D&O Diary (Jan. 4, 2022), available here
- Guest Post: D&O Risks and Challenges for Pharmaceutical Companies and their Insurers, Guest Post, The D&O Diary (Dec. 1, 2021), available here
- Guest Post: The Impending Bankruptcy Surge and Insured vs. Insured Considerations, The D&O Diary (July 27, 2020), available here
- Guest Post: Key 2019 Management and Professional Liability Insurance Coverage Decisions, The D&O Diary (Feb. 5, 2020), available here
- Expert Analysis: PE Leaders’ Many Hats Complicate D&O Policies, Law 360 (July 9, 2019), available here
- Guest Post: Courts Reject Wage and Hour Claims as Employment-Related Misrepresentation Theory, The D&O Diary (May 20, 2019), available here
- Affiliate Transfers: A Practical Guide for Migrating Insurance Policies Between Legal Entities, The Regulator 14 (Aug. 1, 2018), available here
- Class Action Waivers and the Vindication of Statutory Rights: What Has Happened Since AT&T v. Concepcion?, 6 Resolved J. Alternate Disp. Resol. 38 (2016).
Firm and Practice Management
Ohio Super Lawyers Rising Star 2023
Affiliations and Civic Involvement
Member, Columbus Bar Association
Member, Ohio State Bar Association
James focuses his practice on directors and officers liability insurance, professional liability insurance, and coverage litigation. He serves as coverage and monitoring counsel for insurance companies that provide primary and excess coverage to a broad spectrum of policyholders, including public and private companies, investment funds, and municipalities. James is proactive and strategic in advancing his clients’ interests, and he enjoys positioning the carriers he represents to achieve the optimal outcome in any given scenario.
In addition to his coverage work, James assists insurance carriers with regulatory and corporate matters, including licensure issues, product regulation, and M&A deals. In all aspects of his practice, James is committed to providing his clients with the most effective counsel and representation for their legal needs.
Practice Areas
Education
The Ohio State University Moritz College of Law (J.D., 2015) cum laude
The Ohio State University (B.A., 2010) cum laude
Bar Admissions
Ohio
Publications & Speaking Engagements
- 7th Circuit Joins Trend Of No CGL Coverage For Structural Flaws
- Guest Post: Litigation Risks and Insurance Issues for SPAC Sponsors, The D&O Diary (Feb. 15, 2022), available here
- Guest Post: The Year in Review: 2021 Key D&O Insurance Coverage Decisions, The D&O Diary (Jan. 25, 2022), available here
- Guest Post: Divergent Trends Regarding Application of the Insured vs. Insured Exclusion for Mixed Actions, Guest Post, The D&O Diary (Jan. 4, 2022), available here
- Guest Post: D&O Risks and Challenges for Pharmaceutical Companies and their Insurers, Guest Post, The D&O Diary (Dec. 1, 2021), available here
- Guest Post: The Impending Bankruptcy Surge and Insured vs. Insured Considerations, The D&O Diary (July 27, 2020), available here
- Guest Post: Key 2019 Management and Professional Liability Insurance Coverage Decisions, The D&O Diary (Feb. 5, 2020), available here
- Expert Analysis: PE Leaders’ Many Hats Complicate D&O Policies, Law 360 (July 9, 2019), available here
- Guest Post: Courts Reject Wage and Hour Claims as Employment-Related Misrepresentation Theory, The D&O Diary (May 20, 2019), available here
- Affiliate Transfers: A Practical Guide for Migrating Insurance Policies Between Legal Entities, The Regulator 14 (Aug. 1, 2018), available here
- Class Action Waivers and the Vindication of Statutory Rights: What Has Happened Since AT&T v. Concepcion?, 6 Resolved J. Alternate Disp. Resol. 38 (2016).
Firm and Practice Management
Ohio Super Lawyers Rising Star 2023
Affiliations and Civic Involvement
Member, Columbus Bar Association
Member, Ohio State Bar Association
Over the past two years, special purpose acquisition companies (“SPACs”) have become a popular means of taking private companies public. SPACs accounted for 247 public listings in 2020 (52% of all initial public offerings (“IPOs”) for that year) and 613... Read More
It goes without saying that the existence of a “claim” is a fundamental requirement to claims-made coverage, and what falls within the scope of a particular policy’s definition of a “claim” is a question that frequently arises in D&O coverage... Read More
Over the past several decades, pharmaceutical companies have emerged as favored targets for securities class actions. As a result of that trend, the stakes are high for D&O insurers as well as pharmaceutical companies seeking to purchase D&O coverage. This... Read More